ArticleInternational journal of oncology2016

Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition.

Nikolaos Ioannou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.